Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors

Electrochemotherapy (ECT) has evolved significantly during the last decade, expanding treatment indications from superficial skin lesions to advanced-stage, deep-seated tumors in hard-to-reach areas. Electrodes have also shown steady technological improvement throughout the years. Besides standard a...

Full description

Bibliographic Details
Main Authors: Aurel Ottlakan, Gyorgy Lazar, Judit Olah, Andras Nagy, Gabor Vass, Marton Vas, Raissa Pereira, Erika Kis
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Electrochem
Subjects:
Online Access:https://www.mdpi.com/2673-3293/4/2/19
_version_ 1827737676582748160
author Aurel Ottlakan
Gyorgy Lazar
Judit Olah
Andras Nagy
Gabor Vass
Marton Vas
Raissa Pereira
Erika Kis
author_facet Aurel Ottlakan
Gyorgy Lazar
Judit Olah
Andras Nagy
Gabor Vass
Marton Vas
Raissa Pereira
Erika Kis
author_sort Aurel Ottlakan
collection DOAJ
description Electrochemotherapy (ECT) has evolved significantly during the last decade, expanding treatment indications from superficial skin lesions to advanced-stage, deep-seated tumors in hard-to-reach areas. Electrodes have also shown steady technological improvement throughout the years. Besides standard and VEG (variable geometry electrode) electrodes, the introduction of laparoscopic electrodes has brought on a new era in ECT treatment, making the minimally invasive approach a reality. The exact role of ECT in the oncological dashboard is yet to be determined; however, increased tumor response, pain relief, and a low number of adverse events may yield the way for more widespread application of the technique with possible further inclusion of ECT in international oncological guidelines. The aim of this review is to give an overview on the current status of ECT in deep-seated tumor treatment and shed light on its emerging role in local anticancer therapy.
first_indexed 2024-03-11T02:32:50Z
format Article
id doaj.art-94304e05748d4e17be28863e70da42d0
institution Directory Open Access Journal
issn 2673-3293
language English
last_indexed 2024-03-11T02:32:50Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Electrochem
spelling doaj.art-94304e05748d4e17be28863e70da42d02023-11-18T10:07:18ZengMDPI AGElectrochem2673-32932023-05-014228229010.3390/electrochem4020019Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue TumorsAurel Ottlakan0Gyorgy Lazar1Judit Olah2Andras Nagy3Gabor Vass4Marton Vas5Raissa Pereira6Erika Kis7Department of Surgery, University of Szeged, Semmelweis Str. 8, 6720 Szeged, HungaryDepartment of Surgery, University of Szeged, Semmelweis Str. 8, 6720 Szeged, HungaryDepartment of Oncotherapy, University of Szeged, Koranyi Alley 12, 6720 Szeged, HungaryDepartment of Radiology, University of Szeged, 6720 Szeged, HungaryDepartment of Dermatology and Allergology, University of Szeged, Koranyi Alley 6, 6720 Szeged, HungaryDepartment of Surgery, University of Szeged, Semmelweis Str. 8, 6720 Szeged, HungaryDepartment of Surgery, University of Szeged, Semmelweis Str. 8, 6720 Szeged, HungaryDepartment of Dermatology and Allergology, University of Szeged, Koranyi Alley 6, 6720 Szeged, HungaryElectrochemotherapy (ECT) has evolved significantly during the last decade, expanding treatment indications from superficial skin lesions to advanced-stage, deep-seated tumors in hard-to-reach areas. Electrodes have also shown steady technological improvement throughout the years. Besides standard and VEG (variable geometry electrode) electrodes, the introduction of laparoscopic electrodes has brought on a new era in ECT treatment, making the minimally invasive approach a reality. The exact role of ECT in the oncological dashboard is yet to be determined; however, increased tumor response, pain relief, and a low number of adverse events may yield the way for more widespread application of the technique with possible further inclusion of ECT in international oncological guidelines. The aim of this review is to give an overview on the current status of ECT in deep-seated tumor treatment and shed light on its emerging role in local anticancer therapy.https://www.mdpi.com/2673-3293/4/2/19electrochemotherapybleomycindeep-seated tumorpain reliefvariable electrode geometry
spellingShingle Aurel Ottlakan
Gyorgy Lazar
Judit Olah
Andras Nagy
Gabor Vass
Marton Vas
Raissa Pereira
Erika Kis
Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
Electrochem
electrochemotherapy
bleomycin
deep-seated tumor
pain relief
variable electrode geometry
title Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
title_full Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
title_fullStr Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
title_full_unstemmed Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
title_short Current Updates in Bleomycin-Based Electrochemotherapy for Deep-Seated Soft-Tissue Tumors
title_sort current updates in bleomycin based electrochemotherapy for deep seated soft tissue tumors
topic electrochemotherapy
bleomycin
deep-seated tumor
pain relief
variable electrode geometry
url https://www.mdpi.com/2673-3293/4/2/19
work_keys_str_mv AT aurelottlakan currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT gyorgylazar currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT juditolah currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT andrasnagy currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT gaborvass currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT martonvas currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT raissapereira currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors
AT erikakis currentupdatesinbleomycinbasedelectrochemotherapyfordeepseatedsofttissuetumors